Experience with hemoadsorption (CytoSorb®) in the management of septic shock patients

doi:10.5492/wjccm.v9.i1.1

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9097)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-6) series.

Item

Count

PDF

611

WORD

251

HTML

4987

Figures (1-4)

304

Tables (1-6)

381

Sum=6534

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

852

Download

1711

Sum=2563

Jan 31, 2020 (publication date) through Aug 23, 2024

Times Cited of This Article

Times Cited (35)

Journal Information of This Article

Publication Name

World Journal of Critical Care Medicine

ISSN

2220-3141

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Crit Care Med. Jan 31, 2020; 9(1): 1-12
Published online Jan 31, 2020. doi: 10.5492/wjccm.v9.i1.1

Table 5 Cytokine assay (survivor group) (mean ± SD)

Cytokine (pg)	Pre CytoSorb^® therapy	Post CytoSorb^® therapy	Percentage decrease	P value
IL-1	3.82 ± 3.12	2.97 ± 2.99	22.25	0.2172
IL-6	1962.04 ± 229.09	254.09 ± 223.62	87	< 0.0001^a
IL-10	293.75 ± 176.28	124.33 ± 73.61	91.7	< 0.0001^a
TNF	20.82 ± 5.74	15.86 ± 6.11	23.82	0.0003^a

^aP < 0.05, significant value. IL: Interleukin; TNF: Tumour necrosis factor.

Citation: Mehta Y, Mehta C, Kumar A, George JV, Gupta A, Nanda S, Kochhar G, Raizada A. Experience with hemoadsorption (CytoSorb^®) in the management of septic shock patients. World J Crit Care Med 2020; 9(1): 1-12
URL: https://www.wjgnet.com/2220-3141/full/v9/i1/1.htm
DOI: https://dx.doi.org/10.5492/wjccm.v9.i1.1